Andreas O Eggert - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Andreas O Eggert

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005

[Chronic favus caused by infection with Trichophyton schönleinii]Andreas O Eggert, Susanne Grunewald, Ingrid Müller, et al.

Cancer Immunology, Immunotherapy : CII|September 15, 2005

Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cellsDavid Schrama, Heike Voigt, Andreas O Eggert, et al.

International Immunology|July 29, 2003

MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathwaysMartin Leverkus, Alexander D McLellan, Martina Heldmann, et al.

European Journal of Immunology|April 2, 2009

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopesUta B Hofmann, Heike Voigt, Mads H Andersen, et al.

European Journal of Immunology|September 24, 2004

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopesAndreas O Eggert, Mads H Andersen, Heike Voigt, et al.

European Journal of Immunology|January 5, 2002

Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell cultureAndreas O Eggert, Jürgen C Becker, Michael Ammon, et al.

Cancer Immunology, Immunotherapy : CII|December 30, 2006

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expressionMarion Wobser, Heike Voigt, Roland Houben, et al.

The American Journal of Pathology|February 25, 2003

Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancyUlrike Kämmerer, Andreas O Eggert, Michaela Kapp, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004

Shift from systemic to site-specific memory by tumor-targeted IL-2David Schrama, Rong Xiang, Andreas O Eggert, et al.

Cancer Immunology, Immunotherapy : CII|July 3, 2007

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissueDavid Schrama, Heike Voigt, Andreas O Eggert, et al.

Pageof 1

Search research articles

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005

[Chronic favus caused by infection with Trichophyton schönleinii]Andreas O Eggert, Susanne Grunewald, Ingrid Müller, et al.

Cancer Immunology, Immunotherapy : CII|September 15, 2005

Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cellsDavid Schrama, Heike Voigt, Andreas O Eggert, et al.

International Immunology|July 29, 2003

MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathwaysMartin Leverkus, Alexander D McLellan, Martina Heldmann, et al.

European Journal of Immunology|April 2, 2009

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopesUta B Hofmann, Heike Voigt, Mads H Andersen, et al.

European Journal of Immunology|September 24, 2004

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopesAndreas O Eggert, Mads H Andersen, Heike Voigt, et al.

European Journal of Immunology|January 5, 2002

Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell cultureAndreas O Eggert, Jürgen C Becker, Michael Ammon, et al.

Cancer Immunology, Immunotherapy : CII|December 30, 2006

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expressionMarion Wobser, Heike Voigt, Roland Houben, et al.

The American Journal of Pathology|February 25, 2003

Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancyUlrike Kämmerer, Andreas O Eggert, Michaela Kapp, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004

Shift from systemic to site-specific memory by tumor-targeted IL-2David Schrama, Rong Xiang, Andreas O Eggert, et al.

Cancer Immunology, Immunotherapy : CII|July 3, 2007

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissueDavid Schrama, Heike Voigt, Andreas O Eggert, et al.

Pageof 1